ARPE-19 cells were obtained from the American Type Culture Collection (passage 22; Manassas, VA) or were gifts of Colin Barnstable (passage 24; Yale University) or Nancy Philp (passage 21; Thomas Jefferson University, Philadelphia, PA). The cells were used at passages 24 to 26 and were maintained in tissue culture flasks in DMEM-F12 (Invitrogen, Carlsbad, CA) containing 2% fetal bovine serum (FBS; Invitrogen) until they were postconfluence for several weeks. Then, the cells were harvested and plated in DMEM-F12, 2% FBS on glass coverslips or laminin-coated clear filters (Transwell; Fisher Scientific, Hampton, NH) at a density of 1.8 × 10
5 cells/cm
2. The filters subdivide the culture dish into two medium chambers to enable studies of transmonolayer permeability. Electrodes may be placed in the apical and basal chambers to measure the TER, or a tracer may be placed in the apical chamber to measure its diffusion into the basal chamber. The cultures rapidly became confluent. At 4 days after confluence, the culture medium was changed to the desired medium: (1) DMEM-F12 was supplemented with 1% FBS. This medium yielded cultures with native morphology in earlier studies.
6 (2) Triple medium (a 1:1:1 mix of Ham F12, MCBD 131, and Medium 199 [Invitrogen]) was supplemented with ITS
+, an insulin-transferrin-selenium-BSA–linoleic acid mixture (BD Biosciences, Bedford, MA);
l-glutamate; and 0.5% to 5% FBS. Triple medium was formulated with the purpose of establishing RPE-endothelial cell cocultures. (3) SF3 medium was a serum-free medium supplemented with ITS
+ for cultures of chick RPE.
4 (4) JTT medium is a low-serum medium, supplemented with ITS
+ and 0.2% FBS that promoted the expression of RPE-specific proteins and was generously supplied by Joyce Tombran-Tink (University of Missouri, Kansas City, MO). Culture media were changed weekly.